Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
Researchers from Purdue University, Department of Chemistry describe findings in immunotherapy
June 18th, 2008
Current study results from the report, 'Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy,' have been published. "Human cancers frequently overexpress a high-affinity cell-surface receptor for the vitamin folic acid. Highly immunogenic haptens can be targeted to folate receptor-expressing cell surfaces by administration of folate-hapten conjugates, rendering the decorated tumor cell surfaces more recognizable by the immune system," scientists writing in the International Journal of Radiation, Oncology, Biology, Physics report. "Treatment of antihapten-immunized mice with folate-hapten constructs results in...
Source: Vaccine Weekly (2008-06-18)
|
